Clinical Trial: Automated Capture of Core Data for Rare Diseases and Glucocorticoid Complications: Biomarkers and Patient-Reported Outcomes

U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07916415) titled 'Automated Capture of Core Data for Rare Diseases and Glucocorticoid Complications: Biomarkers and Patient-Reported Outcomes' on Oct. 29.

Brief Summary: Main goal: Looking for biological markers (molecular and biochemical) that predict glucocorticoid complications using blood and urine samples.

Evaluation criterion: statistical association between biological markers and the occurrence of glucocorticoid complications.

Glucocorticoid-related complications are collected in a research program called "CDE.AI" (common data elements, artificial intelligence). CDE.AI aims at processing unstructured medical reports with natural language proc...